Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohiro Asai

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Biological & Pharmaceutical Bulletin|November 6, 2012
Nanoparticle-mediated delivery of anticancer agents to tumor angiogenic vesselsTomohiro Asai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2012
[Positron emission tomography (PET) imaging of small interfering RNA (siRNA) delivery in drug development]Tomohiro Asai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2016
[Frontier Pharmaceutics to Be Explored by Young Scientists: DDS Research for Innovative Drug Development]Tomohiro Asai, Masanori Tachikawa
Methods in Enzymology|February 22, 2005
Liposomalized oligopeptides in cancer therapyTomohiro Asai, Naoto Oku
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2010
Angiogenic vessel-targeting DDS by liposomalized oligopeptidesTomohiro Asai, Naoto Oku
Biological & Pharmaceutical Bulletin|February 5, 2014
Systemic delivery of small RNA using lipid nanoparticlesTomohiro Asai, Naoto Oku
Advanced Drug Delivery Reviews|August 10, 2020
Recent advances in siRNA delivery mediated by lipid-based nanoparticlesSei Yonezawa, Hiroyuki Koide, Tomohiro Asai
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2007
Effective tumor regression by anti-neovascular therapy in hypovascular orthotopic pancreatic tumor modelSei Yonezawa, Tomohiro Asai, Naoto Oku
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
siRNA Vehicles for High Endosomal EscapabilityHiroyuki Koide, Sei Yonezawa, Tomohiro Asai
Expert Opinion on Therapeutic Targets|March 11, 2005
Antineovascular therapy, a novel antiangiogenic approachKosuke Shimizu, Tomohiro Asai, Naoto Oku
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Biological & Pharmaceutical Bulletin|November 6, 2012
Nanoparticle-mediated delivery of anticancer agents to tumor angiogenic vesselsTomohiro Asai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2012
[Positron emission tomography (PET) imaging of small interfering RNA (siRNA) delivery in drug development]Tomohiro Asai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2016
[Frontier Pharmaceutics to Be Explored by Young Scientists: DDS Research for Innovative Drug Development]Tomohiro Asai, Masanori Tachikawa
Methods in Enzymology|February 22, 2005
Liposomalized oligopeptides in cancer therapyTomohiro Asai, Naoto Oku
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2010
Angiogenic vessel-targeting DDS by liposomalized oligopeptidesTomohiro Asai, Naoto Oku
Biological & Pharmaceutical Bulletin|February 5, 2014
Systemic delivery of small RNA using lipid nanoparticlesTomohiro Asai, Naoto Oku
Advanced Drug Delivery Reviews|August 10, 2020
Recent advances in siRNA delivery mediated by lipid-based nanoparticlesSei Yonezawa, Hiroyuki Koide, Tomohiro Asai
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2007
Effective tumor regression by anti-neovascular therapy in hypovascular orthotopic pancreatic tumor modelSei Yonezawa, Tomohiro Asai, Naoto Oku
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
siRNA Vehicles for High Endosomal EscapabilityHiroyuki Koide, Sei Yonezawa, Tomohiro Asai
Expert Opinion on Therapeutic Targets|March 11, 2005
Antineovascular therapy, a novel antiangiogenic approachKosuke Shimizu, Tomohiro Asai, Naoto Oku
Pageof 17